Content area
Full text
About the Authors:
Chad J. Johnson
Affiliation: Environmental Chemistry and Technology Program and Department of Soil Science, University of Wisconsin, Madison, Wisconsin, United States of America
Judd M. Aiken
Affiliation: Center for Prions and Protein Misfolding Diseases, University of Alberta, Edmonton, Alberta, Canada
Debbie McKenzie
Affiliation: Center for Prions and Protein Misfolding Diseases, University of Alberta, Edmonton, Alberta, Canada
Michael D. Samuel
Affiliation: U.S. Geological Survey, Wisconsin Cooperative Wildlife Research Unit, University of Wisconsin, Madison, Wisconsin, United States of America
Joel A. Pedersen
* E-mail: [email protected]
Affiliation: Environmental Chemistry and Technology Program and Department of Soil Science, University of Wisconsin, Madison, Wisconsin, United States of America
Introduction
Transmissible spongiform encephalopathies (TSEs) or prion diseases are a class of rare progressive neurodegenerative diseases and include scrapie in sheep, bovine spongiform encephalopathy in cattle, and chronic wasting disease (CWD) in deer, elk and moose, and Creutzfeldt-Jakob disease in humans. The etiological agents in TSEs lack specific nucleic acid and are referred to as prions. Substantial experimental evidence indicates that prions are composed primarily, if not solely, of a disease-associated conformer of the host-encoded prion protein (PrP) [1], [2]. The central biochemical event in the propagation of prion diseases is the refolding of the normal cellular prion protein (PrPC) into a disease-associated conformer (PrPTSE), a substantial fraction of which partially resists digestion by proteinase K (PK) and is denoted PrPres. The precise molecular mechanism of PrPC-to-PrPTSE conversion is unknown. Template-assisted refolding and nucleation-polymerization models have been advanced as mechanisms [3], [4]. The multiple stable conformations of PrPTSE lead to the phenomenon of a single protein being able to encipher multiple strains.
Protein misfolding cyclic amplification (PMCA) [5] has emerged as an important technique for detecting low levels of PrPres in biological samples [6]–[8]. PMCA exploits the ability of PrPTSE to catalyze the conversion of PrPC to the misfolded isoform in a manner conceptually similar to the polymerase chain reaction. The amount of PrPres is increased by successive cycles of sonication (to disrupt PrPTSE aggregates) and amplification using PrPC from brain homogenate as a substrate. Sensitivity can be increased by replenishing the substrate after a round of PMCA (one round consists of...